Banks - Regional
Build Your Comparison
Side-by-side financial analysisStock Comparison
PROV vs HOMB vs JPM
Revenue, margins, valuation, and 5-year total return — side by side.
Banks - Regional
Banks - Diversified
PROV vs HOMB vs JPM — Key Financials
Market cap, revenue, margins, and valuation side-by-side.
| Company Snapshot | |||
|---|---|---|---|
| Industry | Banks - Regional | Banks - Regional | Banks - Diversified |
| Market Cap | $109M | $5.58B | $896.00B |
| Revenue (TTM) | $60M | $1.37B | $280.33B |
| Net Income (TTM) | $7M | $475M | $57.05B |
| Gross Margin | 67.8% | 77.3% | 60.0% |
| Operating Margin | 16.2% | 43.8% | 25.9% |
| Forward P/E | 15.4x | 11.5x | 14.4x |
| Total Debt | $213M | $935M | $942.38B |
| Cash & Equiv. | $53M | $667M | $343.34B |
PROV vs HOMB vs JPM — Long-Term Stock Performance
Price return indexed to 100 at period start. Dividends excluded.
| Stock | Jun 20 | Jun 26 | Return |
|---|---|---|---|
| Provident Financial… (PROV) | 100 | 127.6 | +27.6% |
| Home Bancshares, In… (HOMB) | 100 | 183.7 | +83.7% |
| JPMorgan Chase & Co. (JPM) | 100 | 341.0 | +241.0% |
Price return only. Dividends and distributions are not included.
Quick Verdict: PROV vs HOMB vs JPM
Each card shows where this stock fits in a portfolio — not just who wins on paper.
PROV is the clearest fit if your priority is income & stability and sleep-well-at-night.
- Dividend streak 0 yrs, beta 0.21, yield 3.3%
- Lower volatility, beta 0.21, current ratio 0.06x
- Beta 0.21, yield 3.3%, current ratio 0.06x
HOMB is the clearest fit if your priority is bank quality.
- NIM 3.8% vs JPM's 2.2%
- Efficiency ratio 0.3% vs PROV's 0.5% (lower = leaner)
- Efficiency ratio 0.3% vs PROV's 0.5%
JPM has the current edge in this matchup, primarily because of its strength in growth exposure and long-term compounding.
- Rev growth 3.3%, EPS growth 1.5%
- 465.8% 10Y total return vs HOMB's 57.7%
- PEG 0.81 vs HOMB's 0.87
See the full category breakdown
| Category | Winner | Why |
|---|---|---|
| Growth | 3.3% NII/revenue growth vs HOMB's -5.3% | |
| Value | Lower P/E (14.4x vs 15.4x) | |
| Quality / Margins | Efficiency ratio 0.3% vs PROV's 0.5% (lower = leaner) | |
| Stability / Safety | Beta 0.21 vs JPM's 0.94, lower leverage | |
| Dividends | 3.3% yield, vs HOMB's 2.8% | |
| Momentum (1Y) | +21.8% vs HOMB's +3.0% | |
| Efficiency (ROA) | Efficiency ratio 0.3% vs PROV's 0.5% |
PROV vs HOMB vs JPM — Revenue Breakdown by Segment
How each company's revenue is distributed across its business units
PROV vs HOMB vs JPM — Financial Metrics
Side-by-side numbers across 3 stocks — who leads on profitability, valuation, growth, and risk.
Income & Cash Flow (Last 12 Months)
HOMB leads this category, winning 3 of 5 comparable metrics.
Income & Cash Flow (Last 12 Months)
JPM is the larger business by revenue, generating $280.3B annually — 4661.3x PROV's $60M. HOMB is the more profitable business, keeping 34.6% of every revenue dollar as net income compared to PROV's 11.0%.
| Metric | |||
|---|---|---|---|
| RevenueTrailing 12 months | $60M | $1.4B | $280.3B |
| EBITDAEarnings before interest/tax | $12M | $618M | $81.4B |
| Net IncomeAfter-tax profit | $7M | $475M | $57.0B |
| Free Cash FlowCash after capex | $9M | $311M | $100.9B |
| Gross MarginGross profit ÷ Revenue | +67.8% | +77.3% | +60.0% |
| Operating MarginEBIT ÷ Revenue | +16.2% | +43.8% | +25.9% |
| Net MarginNet income ÷ Revenue | +11.0% | +34.6% | +20.4% |
| FCF MarginFCF ÷ Revenue | +15.3% | +22.6% | +36.0% |
| Rev. Growth (YoY)Latest quarter vs prior year | — | — | — |
| EPS Growth (YoY)Latest quarter vs prior year | +69.2% | +26.0% | +16.0% |
Valuation Metrics
HOMB leads this category, winning 4 of 7 comparable metrics.
Valuation Metrics
At 11.7x trailing earnings, HOMB trades at a 36% valuation discount to PROV's 18.4x P/E. Adjusting for growth (PEG ratio), HOMB offers better value at 0.89x vs JPM's 0.90x — a lower PEG means you pay less per unit of expected earnings growth.
| Metric | |||
|---|---|---|---|
| Market CapShares × price | $109M | $5.6B | $896.0B |
| Enterprise ValueMkt cap + debt − cash | $269M | $5.9B | $1.50T |
| Trailing P/EPrice ÷ TTM EPS | 18.40x | 11.72x | 16.00x |
| Forward P/EPrice ÷ next-FY EPS est. | 15.41x | 11.47x | 14.40x |
| PEG RatioP/E ÷ EPS growth rate | — | 0.89x | 0.90x |
| EV / EBITDAEnterprise value multiple | 21.77x | 9.47x | 18.36x |
| Price / SalesMarket cap ÷ Revenue | 1.81x | 4.06x | 3.20x |
| Price / BookPrice ÷ Book value/share | 0.90x | 1.30x | 2.47x |
| Price / FCFMarket cap ÷ FCF | 13.38x | 11.58x | 8.88x |
Profitability & Efficiency
HOMB leads this category, winning 6 of 9 comparable metrics.
Profitability & Efficiency
JPM delivers a 15.9% return on equity — every $100 of shareholder capital generates $16 in annual profit, vs $5 for PROV. HOMB carries lower financial leverage with a 0.22x debt-to-equity ratio, signaling a more conservative balance sheet compared to JPM's 2.60x. On the Piotroski fundamental quality scale (0–9), PROV scores 6/9 vs JPM's 5/9, reflecting solid financial health.
| Metric | |||
|---|---|---|---|
| ROE (TTM)Return on equity | +5.1% | +11.4% | +15.9% |
| ROA (TTM)Return on assets | +0.5% | +2.1% | +1.3% |
| ROICReturn on invested capital | +1.9% | +8.7% | +4.5% |
| ROCEReturn on capital employed | +2.4% | +11.5% | +8.9% |
| Piotroski ScoreFundamental quality 0–9 | 6 | 6 | 5 |
| Debt / EquityFinancial leverage | 1.66x | 0.22x | 2.60x |
| Net DebtTotal debt minus cash | $160M | $268M | $599.0B |
| Cash & Equiv.Liquid assets | $53M | $667M | $343.3B |
| Total DebtShort + long-term debt | $213M | $935M | $942.4B |
| Interest CoverageEBIT ÷ Interest expense | 0.47x | 1.47x | 0.74x |
Total Returns (Dividends Reinvested)
JPM leads this category, winning 5 of 6 comparable metrics.
Total Returns (Dividends Reinvested)
A $10,000 investment in JPM five years ago would be worth $21,820 today (with dividends reinvested), compared to $11,816 for PROV. Over the past 12 months, JPM leads with a +21.8% total return vs HOMB's +3.0%. The 3-year compound annual growth rate (CAGR) favors JPM at 33.6% vs HOMB's 9.5% — a key indicator of consistent wealth creation.
| Metric | |||
|---|---|---|---|
| YTD ReturnYear-to-date | +8.8% | +2.7% | -0.5% |
| 1-Year ReturnPast 12 months | +14.5% | +3.0% | +21.8% |
| 3-Year ReturnCumulative with dividends | +50.9% | +31.2% | +138.2% |
| 5-Year ReturnCumulative with dividends | +18.2% | +22.1% | +118.2% |
| 10-Year ReturnCumulative with dividends | +25.8% | +57.7% | +465.8% |
| CAGR (3Y)Annualised 3-year return | +14.7% | +9.5% | +33.6% |
Risk & Volatility
PROV leads this category, winning 2 of 2 comparable metrics.
Risk & Volatility
PROV is the less volatile stock with a 0.21 beta — it tends to amplify market swings less than JPM's 0.94 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. PROV currently trades 98.2% from its 52-week high vs HOMB's 91.6% drawdown — a narrower gap to the peak suggests stronger recent price momentum.
| Metric | |||
|---|---|---|---|
| Beta (5Y)Sensitivity to S&P 500 | 0.21x | 0.66x | 0.94x |
| 52-Week HighHighest price in past year | $17.42 | $30.83 | $337.25 |
| 52-Week LowLowest price in past year | $14.95 | $25.50 | $262.71 |
| % of 52W HighCurrent price vs 52-week peak | +98.2% | +91.6% | +95.1% |
| RSI (14)Momentum oscillator 0–100 | 48.8 | 63.7 | 59.1 |
| Avg Volume (50D)Average daily shares traded | 8K | 1.4M | 7.0M |
Analyst Outlook
Evenly matched — PROV and HOMB and JPM each lead in 1 of 2 comparable metrics.
Analyst Outlook
Analyst consensus: PROV as "Hold", HOMB as "Hold", JPM as "Buy". Consensus price targets imply 11.5% upside for HOMB (target: $32) vs -6.5% for PROV (target: $16). For income investors, PROV offers the higher dividend yield at 3.26% vs JPM's 1.86%.
| Metric | |||
|---|---|---|---|
| Analyst RatingConsensus buy/hold/sell | Hold | Hold | Buy |
| Price TargetConsensus 12-month target | $16.00 | $31.50 | $339.75 |
| # AnalystsCovering analysts | 10 | 19 | 61 |
| Dividend YieldAnnual dividend ÷ price | +3.3% | +2.8% | +1.9% |
| Dividend StreakConsecutive years of raises | 0 | 15 | 15 |
| Dividend / ShareAnnual DPS | $0.56 | $0.80 | $5.95 |
| Buyback YieldShare repurchases ÷ mkt cap | +4.1% | +1.5% | +3.9% |
HOMB leads in 3 of 6 categories (Income & Cash Flow, Valuation Metrics). JPM leads in 1 (Total Returns). 1 tied.
PROV vs HOMB vs JPM: Key Questions Answered
10 questions · data-driven answers · updated daily
01Is PROV or HOMB or JPM a better buy right now?
For growth investors, JPMorgan Chase & Co.
(JPM) is the stronger pick with 3. 3% revenue growth year-over-year, versus -5. 3% for Home Bancshares, Inc. (HOMB). Home Bancshares, Inc. (HOMB) offers the better valuation at 11. 7x trailing P/E (11. 5x forward), making it the more compelling value choice. Analysts rate JPMorgan Chase & Co. (JPM) a "Buy" — based on 61 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.
02Which has the better valuation — PROV or HOMB or JPM?
On trailing P/E, Home Bancshares, Inc.
(HOMB) is the cheapest at 11. 7x versus Provident Financial Holdings, Inc. at 18. 4x. On forward P/E, Home Bancshares, Inc. is actually cheaper at 11. 5x. The PEG ratio (P/E divided by earnings growth rate) is the most growth-adjusted single valuation metric: JPMorgan Chase & Co. wins at 0. 81x versus Home Bancshares, Inc. 's 0. 87x — a PEG below 1. 0 traditionally signals the market is underpricing earnings growth.
03Which is the better long-term investment — PROV or HOMB or JPM?
Over the past 5 years, JPMorgan Chase & Co.
(JPM) delivered a total return of +118. 2%, compared to +18. 2% for Provident Financial Holdings, Inc. (PROV). Over 10 years, the gap is even starker: JPM returned +465. 8% versus PROV's +25. 8%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.
04Which is safer — PROV or HOMB or JPM?
By beta (market sensitivity over 5 years), Provident Financial Holdings, Inc.
(PROV) is the lower-risk stock at 0. 21β versus JPMorgan Chase & Co. 's 0. 94β — meaning JPM is approximately 357% more volatile than PROV relative to the S&P 500. On balance sheet safety, Home Bancshares, Inc. (HOMB) carries a lower debt/equity ratio of 22% versus 3% for JPMorgan Chase & Co. — giving it more financial flexibility in a downturn.
05Which is growing faster — PROV or HOMB or JPM?
By revenue growth (latest reported year), JPMorgan Chase & Co.
(JPM) is pulling ahead at 3. 3% versus -5. 3% for Home Bancshares, Inc. (HOMB). On earnings-per-share growth, the picture is similar: Home Bancshares, Inc. grew EPS 19. 9% year-over-year, compared to -12. 3% for Provident Financial Holdings, Inc.. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.
06Which has better profit margins — PROV or HOMB or JPM?
Home Bancshares, Inc.
(HOMB) is the more profitable company, earning 34. 6% net margin versus 10. 4% for Provident Financial Holdings, Inc. — meaning it keeps 34. 6% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: HOMB leads at 43. 8% versus 14. 8% for PROV. At the gross margin level — before operating expenses — HOMB leads at 77. 3%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.
07Is PROV or HOMB or JPM more undervalued right now?
The PEG ratio (forward P/E divided by expected earnings growth rate) is the most precise measure of undervaluation relative to growth potential.
By this metric, JPMorgan Chase & Co. (JPM) is the more undervalued stock at a PEG of 0. 81x versus Home Bancshares, Inc. 's 0. 87x. A PEG below 1. 0 is traditionally considered the threshold for growth-adjusted undervaluation. On forward earnings alone, Home Bancshares, Inc. (HOMB) trades at 11. 5x forward P/E versus 15. 4x for Provident Financial Holdings, Inc. — 3. 9x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for HOMB: 11. 5% to $31. 50.
08Which pays a better dividend — PROV or HOMB or JPM?
All stocks in this comparison pay dividends.
Provident Financial Holdings, Inc. (PROV) offers the highest yield at 3. 3%, versus 1. 9% for JPMorgan Chase & Co. (JPM).
09Is PROV or HOMB or JPM better for a retirement portfolio?
For long-horizon retirement investors, Provident Financial Holdings, Inc.
(PROV) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 0. 21), 3. 3% yield). Both have compounded well over 10 years (PROV: +25. 8%, HOMB: +57. 7%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.
10What are the main differences between PROV and HOMB and JPM?
Both stocks operate in the Financial Services sector, making this a peer-level intra-sector comparison — the same macro tailwinds and headwinds will affect both.
In terms of investment character: PROV is a small-cap income-oriented stock; HOMB is a small-cap deep-value stock; JPM is a large-cap deep-value stock. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.
You Might Also Compare
Based on how these companies actually compete and overlap — not just which sector they're filed under.